Editas Medicine struggles with underwhelming data and lacks major partnerships. Find out why EDIT stock faces significant ...

Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in vivo to treat oncology and autoimmune diseases, today announced the appointment of Joseph Bolen, Ph.D., as Chief ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle ... Edge gives you instant access to all major analyst upgrades, downgrades, and ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

Though it sounds on the surface like a potential cheat code, the bats have been ruled legal by Major League Baseball and there's no reason why every other team cannot use them as well. In fact ...

After getting no major new AI features in iOS 18.3 ... fall—there are lots of improvements in iOS 18.4. The iOS 18.4 beta began on February 21 with a developer beta, and the first public ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Why Google has decided to make people unlock their Pixel phones this way is a mystery. They are going to first launch this cool new feature with the Android 16 beta update. This final update is ...

Meanwhile, BlockDAG (BDAG) has rolled out its Beta Testnet, showcasing efficient parallel transaction processing and rewarding early users with automated smart contract airdrops. While Ethereum and ...